Liver Metastases From Noncolorectal Malignancies (Neuroendocrine Tumor, Sarcoma, Melanoma, Breast).

摘要: Patients with noncolorectal hepatic metastases often face limited treatment options and a dismal prognosis. Over the last decade, advent of targeted immunotherapies has transformed certain metastatic cancers, such as sarcoma melanoma; however, these patients eventually develop resistance. Metastatic sarcoma, melanoma, breast neuroendocrine tumors are notoriously resistant once they have metastasized to liver. For minimally invasive transarterial ablation therapies emerged safe, palliative that can provide symptom control even prolong survival.